• N/A
    Market Cap
  • 0.00%
    1-Year Change
  • Diagnostics & Research
    Industry
Annual
Quarterly
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
12.2M
+134.88%
5.2M
N/A
Cost of Revenue
7.8M
+105.53%
3.8M
N/A
Gross Profit
4.4M
+215.55%
1.4M
N/A
Sales and Marketing Expense
3.5M
+13.83%
3.1M
N/A
Research and Development Expense
-824,000
-91.65%
-9.9M
N/A
Depreciation and Amortization Expense
763,000
+694.79%
96,000
N/A
Total Operating Expenses
9.4M
+243.13%
2.7M
N/A
Operating Profit
-9.3M
-34.89%
-14.3M
N/A
Interest Income
-1.7M
+38.17%
-1.2M
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
-1.7M
+38.17%
-1.2M
N/A
Total Nonoperating Income and Expense
378,000
N/A
N/A
N/A
Income before Taxes
-9.3M
-34.89%
-14.3M
N/A
Income Taxes
N/A
N/A
N/A
N/A
Extraordinary Items
1.5M
N/A
N/A
N/A
Net Income
-43.3M
+45.48%
-29.8M
N/A
Net Income from Continuing Operations Applicable to Common
-43.3M
+45.48%
-29.8M
N/A
Basic EPS and Net Income
-0.06
-45.45%
-0.11
N/A
Diluted EPS and Net Income
-0.06
-45.45%
-0.11
N/A
Basic Weighted Average Shares
679.6M
+162.21%
259.2M
N/A
Diluted Weighted Average Shares
679.6M
+162.21%
259.2M
N/A
Balance Sheet
Cash and Cash Equivalents
189,000
-79.79%
935,000
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
189,000
-79.79%
935,000
N/A
Total Current Assets
4.7M
+92.49%
2.5M
N/A
Accumulated Depreciation
485,000
+132.06%
209,000
N/A
Property and Plant and Equipment and Net
2.0M
+2.30%
2.0M
N/A
Total Long-Term Assets
10.4M
+192.19%
3.6M
N/A
Total Assets
15.1M
+151.54%
6.0M
N/A
Income Taxes Payable
315,000
N/A
N/A
N/A
Total Short-Term Debt
2.0M
+20.99%
1.7M
N/A
Total Current Liabilities
9.0M
+11.04%
8.1M
N/A
Total Long-Term Debt
25.4M
+325.92%
6.0M
N/A
Total Long-Term Liabilities
30.4M
+239.26%
9.0M
N/A
Total Liabilities
9.0M
+11.04%
8.1M
N/A
Retained Earnings
-90.6M
+91.61%
-47.3M
N/A
Total Stockholders Equity
-24.2M
+119.89%
-11.0M
N/A
Total Shares Outstanding
975.6M
+159.25%
376.3M
N/A
Cash Flow
Cash from Operating Activities
-11.2M
+338.78%
-2.6M
N/A
Capital Expenditures
1.1M
-45.96%
2.0M
N/A
Cash from Investing Activities
-4.7M
+30.14%
-3.6M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
15.2M
+114.10%
7.1M
N/A
Financials Ratio
Gross Margin
35.84%
+34.35%
26.68%
N/A
Operating Margin
-75.93%
-72.28%
-273.88%
N/A
Return on Assets
-410.09%
-57.99%
-976.18%
N/A
Return on Equity
245.94%
-28.71%
345.00%
N/A
Revenue Growth
134.88%
N/A
N/A
N/A
Current Ratio
0.53
+73.35%
0.30
N/A
Cash Ratio
0.02
-81.79%
0.12
N/A
Debt-to-Equity Ratio
-1.13
+63.34%
-0.69
N/A
Debt-to-Assets Ratio
1.81
+42.79%
1.27
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow